Raf-1, a potential therapeutic target, mediates early steps in endometriosis lesion development by endometrial epithelial and stromal cells

Endocrinology

Volumn 153, Issue 8, 2012, Pages 3911-3921

  De La Garza, Elizabeth M ^a   Binkley, Peter A ^a   Ganapathy, Manonmani ^a   Krishnegowda, Naveen K ^a   Tekmal, Rajeshwar R ^a,b   Schenken, Robert S ^a   Kirma, Nameer B ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; CASPASE 3; CASPASE 7; RAF PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL LINE; CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; HUMANS; INDOLES; MICE; PHENOLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864381144     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1879     Document Type: Article

References (37)

1. Eskenazi B, Warner ML 1997 Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235-258 (Pubitemid 27225159)
2. Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA, Zondervan KT 2009 Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci 16:335-346
3. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM 1984 Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64:151-154 (Pubitemid 14096684)
4. Maybin JA, Critchley HO, Jabbour HN 2011 Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol 335:42-51
5. Jensen JR, Witz CA, Schenken RS, Tekmal RR 2010 A potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion. Fertil Steril 93:251-256
6. Liu YG, Tekmal RR, Binkley PA, Nair HB, Schenken RS, Kirma NB 2009 Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor β. Mol Hum Reprod 15:665-673
7. Kyriakis JM 2007 The integration of signaling by multiprotein complexes containing Raf kinases. Biochim Biophys Acta 1773:1238-1247 (Pubitemid 47125972)
8. Galabova-Kovacs G, Kolbus A, Matzen D, Meissl K, Piazzolla D, Rubiolo C, Steinitz K, Baccarini M 2006 ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. Cell Cycle 5:1514-1518 (Pubitemid 44091970)
9. Ramos JW 2008 The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40:2707-2719
10. King AJ, Wireman RS, Hamilton M, Marshall MS 2001 Phosphorylation site specificity of the Pak-mediated regulation of Raf-1 and cooperativity with Src. FEBS Lett 497:6-14 (Pubitemid 32480172)
11. Dougherty MK, Müller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD, Conrads TP, Veenstra TD, Lu KP, Morrison DK 2005 Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell 17:215-224 (Pubitemid 40138617)
12. Balan V, Leicht DT, Zhu J, Balan K, Kaplun A, Singh-Gupta V, Qin J, Ruan H, Comb MJ, Tzivion G 2006 Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase. Mol Biol Cell 17:1141-1153 (Pubitemid 43376536)
13. Yoshino O, Osuga Y, Hirota Y, Koga K, Hirata T, Harada M, Morimoto C, Yano T, Nishii O, Tsutsumi O, Taketani Y 2004 Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol 52:306-311 (Pubitemid 39585717)
14. Yotova IY, Quan P, Leditznig N, Beer U, Wenzl R, Tschugguel W 2011 Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod 26:885-897
15. Tian M, Schiemann WP 2009 The TGF-β paradox in human cancer: an update. Future Oncol 5:259-271
16. Komiyama S, Aoki D, Komiyama M, Nozawa S 2007 Local activation of TGF-β1 at endometriosis sites. J Reprod Med 52:306-312 (Pubitemid 46668876)
17. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR 1994 Transforming growth factor-β activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 83:287-292
18. Heldin CH, Miyazono K, ten Dijke P 1997 TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471 (Pubitemid 28013118)
19. Miyazono K, ten Dijke P, Heldin CH 2000 TGF-β signaling by Smad proteins. Adv Immunol 75:115-157
20. Zhang YE 2009 Non-Smad pathways in TGF-β signaling. Cell Res 19:128-139
21. Kirk D, Irwin JC 1980 Normal human endometrium in cell culture. Methods Cell Biol 21B:51-77
22. Ferreira MC, Witz CA, Hammes LS, Kirma N, Petraglia F, Schenken RS, Reis FM 2008 Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum. Mol Hum Reprod 14:301-307 (Pubitemid 351804031)
23. Dechaud H, Witz CA, Montoya-Rodriguez IA, Degraffenreid LA, Schenken RS 2001 Mesothelial cell-associated hyaluronic acid promotes adhesion of endometrial cells to mesothelium. Fertil Steril 76:1012-1018 (Pubitemid 33031330)
24. Desai NN, Kennard EA, Kniss DA, Friedman CI 1994 Novel human endometrial cell line promotes blastocyst development. Fertil Steril 61:760-766 (Pubitemid 24114374)
25. Krikun G, Mor G, Alvero A, Guller S, Schatz F, Sapi E, Rahman M, Caze R, Qumsiyeh M, Lockwood CJ 2004 A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 145:2291-2296 (Pubitemid 38535058)
26. Nair AS, Nair HB, Lucidi RS, Kirchner AJ, Schenken RS, Tekmal RR, Witz CA 2008 Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription. Fertil Steril 90:1487-1495
27. Lehmann K, Janda E, Pierreux CE, Rytömaa M, Schulze A, McMahon M, Hill CS, Beug H, Downward J 2000 Raf induces TGFßproduction while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 14:2610-2622
28. Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM 1996 Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol Cell Biol 16:5839-5845 (Pubitemid 26315105)
29. Ulukus M, Cakmak H, Arici A 2006 The role of endometrium in endometriosis. J Soc Gynecol Investig 13:467-476 (Pubitemid 44528303)
30. Reimann T, Hempel U, Krautwald S, Axmann A, Scheibe R, Seidel D, Wenzel KW 1997 Transforming growth factor-β1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett 403:57-60 (Pubitemid 27079809)
31. Axmann A, Seidel D, Reimann T, Hempel U, Wenzel KW 1998 Transforming growth factor-β1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochem Biophys Res Commun 249:456-460 (Pubitemid 28431775)
32. Sotnikova NY, Antsiferova YS, Shokhina MN 2001 Local epidermal growth factor production in women with endometriosis. Russ J Immunol 6:55-60
33. Luo X, Xu J, Chegini N 2003 Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Reprod Biol Endocrinol 1:125
34. Luo X, Xu J, Chegini N 2003 The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-β. J Clin Endocrinol Metab 88:4967-4976 (Pubitemid 37357551)
35. Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S 2006 Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 5:835-844 (Pubitemid 44480537)
36. Dal Lago L, D'Hondt V, Awada A 2008 Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumors. Oncologist 13:845-858
37. Takimoto CH, Awada A 2008 Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials. Cancer Chemother Pharmacol 61:535-548